RACCAGNI, ANGELO ROBERTO
 Distribuzione geografica
Continente #
EU - Europa 1.976
AS - Asia 1.360
NA - Nord America 1.320
SA - Sud America 222
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 26
OC - Oceania 6
Totale 5.071
Nazione #
US - Stati Uniti d'America 1.240
RU - Federazione Russa 1.173
SG - Singapore 466
CN - Cina 463
BR - Brasile 184
IT - Italia 182
RO - Romania 169
VN - Vietnam 129
DE - Germania 125
HK - Hong Kong 123
FR - Francia 68
GB - Regno Unito 61
FI - Finlandia 50
CA - Canada 42
PL - Polonia 35
IN - India 33
SE - Svezia 27
ID - Indonesia 26
MX - Messico 26
BD - Bangladesh 24
AT - Austria 19
IQ - Iraq 19
NL - Olanda 19
AR - Argentina 18
JP - Giappone 15
ZA - Sudafrica 13
ES - Italia 12
LT - Lituania 12
TR - Turchia 9
MY - Malesia 8
AU - Australia 6
VE - Venezuela 6
BE - Belgio 5
AE - Emirati Arabi Uniti 4
KZ - Kazakistan 4
MA - Marocco 4
NP - Nepal 4
PH - Filippine 4
PK - Pakistan 4
RS - Serbia 4
UA - Ucraina 4
UZ - Uzbekistan 4
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
IR - Iran 3
JO - Giordania 3
PE - Perù 3
SA - Arabia Saudita 3
AL - Albania 2
CR - Costa Rica 2
GT - Guatemala 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
NG - Nigeria 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
GY - Guiana 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PY - Paraguay 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VI - Stati Uniti Isole Vergini 1
Totale 4.910
Città #
Singapore 268
Moscow 212
Ashburn 170
San Jose 156
Hong Kong 121
Dallas 90
Beijing 85
New York 81
Council Bluffs 76
Shanghai 73
Munich 65
Los Angeles 56
Milan 56
Hefei 46
Lauterbourg 41
Santa Clara 39
Ho Chi Minh City 38
Orem 30
Hanoi 29
São Paulo 29
Warsaw 25
Denver 24
Gatchina 23
Turku 22
Boardman 21
St Petersburg 21
London 20
Nuremberg 19
Helsinki 18
Brooklyn 15
Guangzhou 15
Chennai 14
Falkenstein 14
Poplar 14
Tokyo 14
Amsterdam 13
Frankfurt am Main 13
Montreal 13
Toronto 13
Yekaterinburg 13
Atlanta 12
Houston 12
Mexico City 12
Perm 12
Phoenix 11
Rome 11
Seattle 11
Stockholm 11
Chicago 10
Lappeenranta 10
Johannesburg 9
Vienna 9
Jakarta 8
Nizhniy Novgorod 8
Rio de Janeiro 8
Baghdad 7
Cesano Boscone 7
Da Nang 7
Manchester 7
Shenzhen 7
Tianjin 7
Turin 7
Busto Arsizio 6
Haiphong 6
Querétaro 6
San Francisco 6
Voronezh 6
Ankara 5
Boca 5
Boston 5
Brasília 5
Brussels 5
Dhaka 5
Jiaxing 5
Memphis 5
Orlando 5
Paris 5
Philadelphia 5
Wroclaw 5
Barnet 4
Belgrade 4
Calgary 4
Honolulu 4
Istanbul 4
Monsummano Terme 4
Mumbai 4
Naples 4
New Delhi 4
Pisa 4
Pune 4
Rostov-on-Don 4
Secaucus 4
Tashkent 4
Wuxi 4
Almaty 3
Amman 3
Bexley 3
Biên Hòa 3
Buffalo 3
Campodolcino 3
Totale 2.476
Nome #
The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment 252
Viral bloodstream detection in mpox patients: An observational multicentric study 236
Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study 197
Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics 136
Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 136
Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates between 2012 and 2023: Results from an Open Italian Cohort 135
A case of breakthrough mpox infection in an individual non-responder to MVA-BN vaccination 135
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 133
HIV viral load monitoring during monkeypox virus infection among people with HIV 123
Association of high-risk sexual behaviours with sexually transmitted infections among men who have sex with men living with HIV 119
Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience 117
Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report 114
Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination 112
Sexually transmitted infections in men who have sex with men with tenofovir/emtricitabine- or cabotegravir-resistant HIV 110
Viral Hepatitis and Human Papillomavirus Vaccination during HIV Pre-Exposure Prophylaxis: Factors Associated with Missed Vaccination 109
Monkeypox infection among men who have sex with men: PCR testing on seminal fluids 108
High Propensity to Switch to Long-acting Injectable HIV PrEP with Cabotegravir in a Cohort of Oral PrEP Experienced Men who Have Sex with Men in Italy 107
Beyond stigma: Monkeypox infection in a 27-year-old woman 106
Evaluation of analytical performance of the STANDARDTM M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of Monkeypox virus 106
Monkeypox infection in a hemopoietic stem cell and heart transplant recipient 105
Rectal Lymphogranuloma venereum among Men who Have Sex with Men: 7 versus 21 Days Doxycycline Effectiveness 103
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 103
Persistent ocular mpox infection in an immunocompetent individual 102
Isolated monkeypox proctitis among men who have sex with men 100
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 96
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 94
Sexually Transmitted Enteric Infections in Men Who Have Sex With Men Living With HIV Over 8 Years of Follow-up 93
HIV-NAAT use for early detection of HIV infection among high-risk men who have sex with men in Italy 92
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis 92
Antibiotic resistance among sexually transmitted infections: perspectives from clinical practice 89
Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men 88
Viral hepatitis and human papillomavirus vaccination during pre-exposure prophylaxis: factors associated with missed vaccination 86
Role of multi-site sampling in the diagnosis of human Monkeypox 85
Early Diagnosis and Linkage to Care: an Experience over 14 years of Point of Care Rapid HIV Testing 85
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis 84
Two individuals with potential monkeypox virus reinfection 84
Proctitis and prostatitis by Neisseria meningitidis among MSM: A case series 83
Real-life use of cidofovir for the treatment of severe monkeypox cases 79
Vaccines against Emerging Sexually Transmitted Infections: Current Preventive Tools and Future Perspectives 76
Mpox in people with past infection or a complete vaccination course: a global case series 75
Prevalence and Risk Factors of Anal HPV Infection in MSM Living With HIV: Identifying the Target Groups to Prioritize for Immunization 72
Mpox Virus: Control of In-Hospital Occupational Transmission Experience from a Tertiary Level Hospital in Milan, Italy 71
Multidrug-resistant Mycoplasma genitalium urethritis: successful eradication with sequential therapy 68
Rapid improvement of severe Mpox lesions with oral tecovirimat 60
Surge of Mpox Cases in Lombardy Region, Italy, October 2023—January 2024 52
Monkeypox Virus Neutralizing Antibodies at Six Months from Mpox Infection: Virologic Factors Associated with Poor Immunologic Response 50
Unilateral Blepharoconjunctivitis due to Monkeypox Virus Infection 45
HIV and Sexual Health Awareness Among University Students: Findings from a World AIDS Day Survey in Milan 36
Neisseria gonorrhoeae Antimicrobial Resistance: The Future of Antibiotic Therapy 19
Viral blips and virologic failures following mpox vaccination with MVA-BN among people with HIV 14
Gaps in HIV Pre-exposure Prophylaxis Acceptance: Findings from an Outpatient HIV Testing Service in Italy 12
Breakthrough Rectal Neisseria gonorrhoeae Infections After Meningococcal B Vaccination: Microbiological and Clinical Features 10
Doxycycline postexposure prophylaxis may delay seroconversion in incident syphilis 9
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 9
User-reported outcomes of long-acting injectable PrEP with Cabotegravir: Real-world experience from Milan 8
Mpox DNA clearance in semen over 6-month follow-up 8
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs 8
Detection of Mpox Virus in Seminal Fluids: Implications for Sexual Transmission 7
Gonorrhoea and chlamydia screening for asymptomatic people with HIV and HIV PrEP users: open issues 6
A humoral dilemma: reassessing monkeypox virus neutralizing antibodies at more than two years from Mpox or MVA-BN vaccination 6
Implementation of HIV pre-exposure prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE cohort survey 5
Long-term successfull management of recurrent episodes of nontuberculous mycobacterial infection in an apparently healthy Chinese woman 4
Interest and Expectations for a Herpes Vaccine Among People Diagnosed with Genital HSV 1-2 Infection: Results from an Italian Survey 4
Emerging sexually transmitted infections outbreak: Dermatophytosis among men who have sex with men in Milan, Italy 3
Totale 5.071
Categoria #
all - tutte 20.309
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.309


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 1 0 7 0 0
2022/202357 5 2 1 0 1 1 30 11 0 2 3 1
2023/2024266 3 2 39 24 34 68 15 28 0 9 11 33
2024/20251.118 56 11 55 45 79 111 333 93 72 53 79 131
2025/20263.372 247 186 106 406 327 138 283 312 890 256 123 98
2026/2027250 118 132 0 0 0 0 0 0 0 0 0 0
Totale 5.071